We found that the IRLPS-high group had decreased expression of CCL23 (Fig. 2H), in line with our previous study that CCL23 could serve as a tumor suppressor through recruiting CD8+ T cell infiltration in liver cancer43. Here, CCL23 is linked to neoplasm.